Moreover, TRF, hepatocyte Per2 knockout, and ferroptosis inhibition all promoted the expression of PPARα, an important partaker in the pathogenesis of NASH, suggesting that PPARα was likely to be the downstream molecule by which ferroptosis regulated NASH (139). Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.